Many insurers are exiting Medicare Advantage markets in 2025.
There were 3,959 Medicare Advantage plans available nationwide in 2024. The average number of plans available to beneficiaries was 43, unchanged from 2023.
11 insurers exiting Medicare Advantage markets in 2025:
This article was updated Oct. 16 and will continue to be updated
-
Moda Health is discontinuing all individual Medicare Advantage plans and will no longer offer MA plans in Oregon for 2025.
- Premera Blue Cross will not offer Medicare Advantage plans in 2025.
-
MVP Health Care and University of Vermont Health will no longer offer their joint Medicare Advantage plan in Vermont in 2025.
- Cigna Healthcare is exiting Medicare Advantage markets or making service area reductions in eight states for 2025, affecting about 5,400 members.
- Southwestern Health Resources, based in Farmers Branch, Texas, is shutting down its Medicare Advantage plan, Care N' Care. There will be no change for members in 2024.
- Centene will exit a handful of Medicare Advantage markets next year, CEO Sarah London said July 26. The company will no longer offer its Wellcare MA plans in Alabama, Massachusetts, New Hampshire, New Mexico, Rhode Island and Vermont, but will continue to offer prescription drug plans in those states.
- BCBS Arizona will not offer MA prescription drug plans in Arizona in 2025, Becker's confirmed.
- Clear Spring Health will withdraw its Medicare Advantage prescription drug plans from South Carolina and Virginia, Becker's confirmed. The company will still offer plans in Illinois, Georgia (MAPD), and Colorado.
- BCBS Kansas City is exiting the Medicare Advantage market at the end of 2024, citing increasing regulatory requirements and financial headwinds.
- Aetna is bracing to lose up to 10% of its 4.2 million Medicare Advantage members next year as it prioritizes profitability and exits an unknown number of counties where it believes it can't be profitable, executives said in May.
- Humana will exit 13 Medicare Advantage markets in 2025 and see a membership decline, company executives told investors in September.